Harini Gopalakrishnan Joins Vespa.ai as General Manager of Health & Life Sciences
1.5.2025 15:00:00 CEST | Business Wire | Press Release
Vespa.ai, the platform for large-scale, real-time AI applications powered by big data, today announced the appointment of Harini Gopalakrishnan as General Manager of Health & Life Sciences. Gopalakrishnan, formerly Global CTO for Life Sciences at Snowflake, will spearhead Vespa’s strategic initiatives in the sector.
Vespa.ai provides the infrastructure to build and deploy AI-driven applications for search and retrieval-augmented generation (RAG), offering precise, real-time access to large language models (LLMs). In Health and Life Sciences, this capability enables teams to search, connect, and extract insight from complex multimodal data, accelerating research, clinical decision-making, and commercial innovation.
Harini Gopalakrishnan, GM Health & Life Sciences, Vespa.ai: “AI’s success in life sciences depends on unlocking insights across vast data, where one navigates a complex ecosystem of multi-modal data, from omics, protein structures to 3D medical images, from vast scientific literature to internal marketing, regulatory, and compliance documents. Robust agentic RAG applications need sophisticated search engines on your data foundations, optimizing for cost, performance, and quality. Vespa delivers the platform to make this possible, combining high-quality retrieval and ranking across unstructured modalities with enterprise-grade scalability & performance. The future of drug discovery, clinical advancement & commercialization demands these next-generation search capabilities purpose-built for a regulated and scientific industry."
Jon Bratseth, CEO and Founder, Vespa. “AI impact depends on understanding the unique challenges of each industry. Vespa is investing in industry-focused strategies to ensure our platform delivers real value in domains like Health & Life Sciences. No other AI platform matches our ability to meet this sector’s scale, complexity, and latency demands. Harini brings deep expertise and leadership to help us advance our capabilities and better serve the life sciences community.”
About Vespa
Vespa.ai is a powerful platform for developing real-time search-based AI applications. Once built, these applications are deployed through Vespa’s large-scale, distributed architecture, which efficiently manages data, inference, and logic for applications handling large datasets and high concurrent query rates. Vespa delivers all the building blocks of an AI application, including vector database, hybrid search, retrieval augmented generation (RAG), natural language processing (NLP), machine learning, and support for large language models (LLM) and vision language models (VLM). It is available as a managed service and open source.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250430739654/en/
Contacts
Media Contact
Tim Young
timyoung@vespa.ai
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 18:09:00 CEST | Press Release
Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press Release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom